Covington Aids AstraZeneca In $1.3B Ardea Biotech Buy
AstraZeneca PLC will purchase U.S. biotech company Ardea Biosciences Inc., maker of a new gout medicine, for $1.26 billion in cash to beef up its weak late-stage drug pipeline, the buyer...To view the full article, register now.
Already a subscriber? Click here to view full article